Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB) -- Ignore unavailable to you. Want to Upgrade?

To: Heat Shock who wrote (31)	12/13/1997 2:43:00 PM
From: William Marsh	Read Replies (2) \| Respond to of 236

Good news, good publicity, and the stock is in the tiolet! If SSB announced they could raise the dead, the stock would drop a nickel. Does anyone have any explanation other then the fairly dismal market conditions and the lack of interest in biotech development companies? Anything specific to SSB? If it was a reasonable risk a year ago at $3.50, isn't it a better risk now at $2.25? They've made good progress in the last year. I am looking for thoughts and facts. Thanks, Bill